All Pharma News
Laurent Receives Health Canada’s Approval to Initiate Ph 2/3 Trial in Long COVID

Laurent Receives Health Canada’s Approval to Initiate Ph 2/3 Trial in Long COVID
BUSINESSWIRE
29 Aug 2023
Share Share
Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b

Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b
BUSINESSWIRE
03 Nov 2022
Share Share
Laurent Pharma Starts Phase 3 Study With Once-a-Day Oral COVID-19 Antiviral Drug

Laurent Pharma Starts Phase 3 Study With Once-a-Day Oral COVID-19 Antiviral Drug
BUSINESSWIRE
15 Feb 2022
Share Share
Laurent Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b

Laurent Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b
BUSINESSWIRE
15 Dec 2021
Share Share
Laurent’s LAU-7b fails to meet primary goal in Phase II Covid-19 trial

Laurent’s LAU-7b fails to meet primary goal in Phase II Covid-19 trial
CLINICALTRIALSARENA
04 Oct 2021
Share Share
Laurent Announces Topline Results from its Phase 2 RESOLUTION Trial of LAU-7b

Laurent Announces Topline Results from its Phase 2 RESOLUTION Trial of LAU-7b
BUSINESSWIRE
30 Sep 2021
Share Share
Laurent`s COVID oral therapy fails in hospitalized patient trial

Laurent`s COVID oral therapy fails in hospitalized patient trial
Annalee Armstrong FIERCEBIOTECH
30 Sep 2021
Share Share
Laurent Pharma Completes Enrollment in Phase 2 Study of LAU-7b

Laurent Pharma Completes Enrollment in Phase 2 Study of LAU-7b
BUSINESSWIRE
20 May 2021
Share Share
Laurent to continue study of LAU-7b in Covid-19 patients

Laurent to continue study of LAU-7b in Covid-19 patients
CLINICALTRIALSARENA
09 Apr 2021
Share Share
Laurent to continue study of LAU-7b in Covid-19 patients

Laurent to continue study of LAU-7b in Covid-19 patients
CLINICALTRIALSARENA
08 Apr 2021
Share Share